Sales Growth YoY (Last 12 Months): MAIA Biotechnology (MAIA)

Public company logo of MAIA Bio (MAIA)

MAIA Biotechnology is optimizing biomaterial supplies for the development of immuno-oncology agents to maintain margins. The trailing four-quarter annual revenue growth rate confirms the trend, with the figure settling at 0.00. The company is integrating AI into drug synthesis, although medical decisions remain with physicians. Currently, the firm is developing targeted telomere activation methods to combat aggressive lung cancer.

MAIA Biotechnology, Inc. (MAIA) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/16/2026

MAIA Biotechnology, Inc. (MAIA) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:MAIA Biotechnology
Product sample of MAIABiotech.com

This indicator measures commercial revenue dynamics over a rolling year, neutralizing quarterly reporting gaps. By analyzing comparable year-over-year sales growth over 12 months on GURU.Markets, an investor assesses the fundamental scale of the business. The metric captures the percentage change in revenue, determining the stability of cash flows. For MAIA Biotechnology (MAIA), these levels depend on the efficiency of collaboration with external research centers. Controlling outsourcing costs directly impacts the final financial performance.

Competitors of MAIA Biotechnology (MAIA)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|Immix Biopharma - Revenue Growth YoY (Last 12 Months)|ALX Oncology (ALXO) - Trailing Twelve Months Revenue Growth|CUE: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth PDSB|sonnetbio.com (SONN) - Sales Growth YoY (Last Twelve Months)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)